ARESVIQUE Trademark

Trademark Overview


On Thursday, November 11, 2021, a trademark application was filed for ARESVIQUE with the United States Patent and Trademark Office. The USPTO has given the ARESVIQUE trademark a serial number of 97120562. The federal status of this trademark filing is REGISTERED as of Tuesday, January 24, 2023. This trademark is owned by GlaxoSmithKline Biologicals SA. The ARESVIQUE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; (Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatol...
aresvique

General Information


Serial Number97120562
Word MarkARESVIQUE
Filing DateThursday, November 11, 2021
Status700 - REGISTERED
Status DateTuesday, January 24, 2023
Registration Number6960934
Registration DateTuesday, January 24, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 8, 2022

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; (Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 18, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Tuesday, January 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 24, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 5, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, September 30, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, September 28, 2022ATTORNEY REVIEW COMPLETED
Monday, September 26, 2022ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Monday, September 26, 2022PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, August 30, 2022WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Monday, August 29, 2022ASSIGNED TO PETITION STAFF
Tuesday, August 23, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022PUBLISHED FOR OPPOSITION
Thursday, August 11, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, August 3, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 2, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, August 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 20, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, July 15, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, July 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 29, 2022ASSIGNED TO EXAMINER
Thursday, November 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 15, 2021NEW APPLICATION ENTERED